NTR played a critical role in the theranostic approach for treating hepatocellular carcinoma (HCC) by activating the prodrug CB1954 to produce cytotoxic metabolites (Kumar et al., 2023). This evidence concerns the gene NTSR1 and hepatocellular carcinoma.